Get my own profile
Public access
View all42 articles
3 articles
available
not available
Based on funding mandates
Co-authors
- Mikhail SavitskiEMBLVerified email at embl.de
- Nassos TypasGroup Leader, EMBLVerified email at embl.de
- Frank SteinEMBL HeidelbergVerified email at embl.de
- Nils KurzawaCellzome, a GSK companyVerified email at gsk.com
- Per ArturssonUppsala universityVerified email at farmaci.uu.se
- Isabelle BecherEMBL HeidelbergVerified email at embl.de
- Joel SelkrigRWTH University Hospital, Aachen, GermanyVerified email at ukaachen.de
- Dominic HelmProteomics Core Facility, DKFZVerified email at dkfz-heidelberg.de
- Pär MatssonProfessor of Pharmacokinetics, Sahlgrenska Academy, University of GothenburgVerified email at gu.se
- Ana Rita BrochadoTübingen University, GermanyVerified email at uni-wuerzburg.de
- Manuel BanzhafUniversity of Newcastle, EnglandVerified email at newcastle.ac.uk
- Cristina ViéitezInstitute of Funcional Biology and Genomics (IBFG) CSIC-University of SalamancaVerified email at usal.es
- Thomas LundbäckSenior Director, Mechanistic & Structural Biology, R&D, AstraZenecaVerified email at astrazeneca.com
- mike hannGlaxoSmithKlineVerified email at gsk.com
- Brinton Seashore-LudlowKarolinska InstitutetVerified email at ki.se
- Christine WeglerSenior research engineer, Swedish Metabolomics Center, Umeå UniversityVerified email at umu.se
- Anna VildhedeSenior scientist, AstraZenecaVerified email at alumni.chalmers.se
- Bede P. BusbyTeam Manager Ministry for Primary Industries, Bacteriology and Aquatic Animal DiseasesVerified email at mpi.govt.nz
- Felipe CavaUmeå University (Sweden)Verified email at umu.se
- Magnus ÖlanderPostdoctoral researcher, Department of Molecular Biology, Umeå UniversityVerified email at umu.se
Follow
André Mateus
Assistant Professor at Umeå University | Team Leader at Molecular Infection Medicine Sweden (MIMS)
Verified email at umu.se - Homepage